Social phobia, generalized
Methodology & AI Transparency ⓘ
Social phobia, generalized Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Designated in federal medical registries as F40.11, Social phobia, generalized falls under Anxiety & PTSD management, where functional impairment review [Social phobia, generalized F40.11] establishes baseline severity and rules out diagnostic mimics.
- 2 Real-world patient consensus: Clinical coding for Social phobia, generalized uses ICD-10 F40.11 across Anxiety & PTSD specialty care.
- 3 Typical cash cost range: Primary evaluation for Social phobia, generalized incorporates functional impairment review [Social phobia, generalized F40.11] and symptom diary review.
- 4 Top reported side effects / signs: Follow-up benchmark in Social phobia, generalized: maintaining TSH & Ferritin in Social phobia, generalized (F40.11: Rule-Out) within TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F40.11).
Ask our AI Specialists anything about Social phobia, generalized
What Is Social phobia, generalized?
Designated in federal medical registries as F40.11, Social phobia, generalized falls under Anxiety & PTSD management, where functional impairment review [Social phobia, generalized F40.11] establishes baseline severity and rules out diagnostic mimics.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Social phobia, generalized (code F40.11) is autonomic vagal withdrawal [Social phobia, generalized F40.11], which Anxiety, OCD & Trauma Disorders clinicians address while surveilling TSH & Ferritin in Social phobia, generalized (F40.11: Rule-Out) (TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F40.11)).
Common Symptoms & Clinical Signs
- • Presentation of Social phobia, generalized (F40.11): avoidance of triggers, in Social phobia, generalized (F40.11: intrusive trauma memories,)
- • Secondary Social phobia, generalized clinical sign: excessive, hard-to-control anticipatory in Social phobia, generalized (F40.11: worry or intrusive)
- • Symptom flares in Social phobia, generalized correlating with TSH & Ferritin in Social phobia, generalized (F40.11: Rule-Out) deviation outside TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F40.11)
- • Functional anxiety & ptsd impact requiring functional impairment review [Social phobia, generalized F40.11] evaluation (F40.11)
Social phobia, generalized Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F40.11 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Anxiety, OCD & Trauma Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: TSH & Ferritin in Social phobia, generalized (F40.11: Rule-Out) | TSH 0.8–2.5 mIU/L; Ferritin > 50 ng/mL (F40.11) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: GAD-7 Anxiety Severity in Social phobia, generalized (F40.11: Score) | < 4 (minimal anxiety) (F40.11) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Resting Heart Rate in Social phobia, generalized (F40.11: Variability (HRV)) | Stable upward personal trend (F40.11) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Social phobia, generalized
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Venlafaxine Hydrochloride, Extended Release Effexor • RxCUI 808744 | Serotonin and Norepinephrine Reuptake Inhibitor | 87% | $0.2153 | $ 5.86 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Social phobia, generalized)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| What the Latest Evidence Really Says About Drug treatment for panic disorder with or without agoraphobia: systematic review The findings suggest that SSRIs provide high rates of full symptom relief with low risk of side effects for the treatment of panic disorder. BMJ (Clinical research ed.) • 2022-01-19 • Meta-Analysis | Multi-cohort | 92/100 | PMID 35045991 ↗ |
| New Insights on Smoking behavior postmyocardial infarction among ENRICHD trial participants:: What a 1,233-Participant Study Found CBT for depression without more specific attention to smoking cessation may have little overall value as a strategy for helping post-MI patients refrain from smoking. Psychosomatic medicine • 2008-10-15 • Randomized Controlled Trial | N = 1,233 | 90/100 | PMID 18842753 ↗ |
| Can This Approach Help? Inside the Latest Research on Associations between expectations and responses to chronic resistance exercise in Preliminary findings suggest that the mental health benefits of chronic RET were independent of placebo effects, notwithstanding the potential limitations of small sample size and the non-mode-specific measure of expectations. Scientific reports • 2025-12-17 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 41407729 ↗ |
| New Insights on Anxiety, repetitive and restricted behaviors and interests, and social: What a 322-Participant Study Found However, a mediation analysis revealed that the effect of CSCI on anxiety was fully explained by RRB (P = 0.17). Scientific reports • 2025-11-06 • Phase III Randomized Trial | N = 322 | 87/100 | PMID 41198718 ↗ |
| What the Latest Evidence Really Says About Psychosocial impact of androgenetic hair loss on There was limited evidence of a severe impact on mental health and quality of life for men experiencing hair loss, with most studies evidencing (at best) a moderate impact. Psychology, health & medicine • 2024-04-15 • Meta-Analysis | Multi-cohort | 86/100 | PMID 37605428 ↗ |
Social phobia, generalized Patient Community & “People Like Me” Threads
Filter Social phobia, generalized community threads and patient logs by age, biological sex, dosage, and treatment duration.